These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18365478)

  • 21. Gender differences in response to lorazepam in a human drug discrimination study.
    Jackson A; Stephens D; Duka T
    J Psychopharmacol; 2005 Nov; 19(6):614-9. PubMed ID: 16272183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential.
    Nickel B; Borbe HO; Szelenyi I
    Arzneimittelforschung; 1990 Aug; 40(8):905-8. PubMed ID: 1978681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The assessment of the action of pharmacological agents based on a new computer program for analysing animal operant behavior].
    Garibova TL; Voronina TA; Stefankov DV; Kalinina TS
    Farmakol Toksikol; 1990; 53(1):67-70. PubMed ID: 1970311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepines: drug discrimination and physiological dependence.
    Griffiths RR; Ator NA; Lukas SE; Lamb RJ; Brady JV
    NIDA Res Monogr; 1984 Mar; 49():163-4. PubMed ID: 6148692
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
    de Haas SL; de Visser SJ; van der Post JP; Schoemaker RC; van Dyck K; Murphy MG; de Smet M; Vessey LK; Ramakrishnan R; Xue L; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Jan; 22(1):24-32. PubMed ID: 18187530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation.
    Marona-Lewicka D; Nichols DE
    Behav Pharmacol; 2009 Feb; 20(1):114-8. PubMed ID: 19179855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
    de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
    J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of benzodiazepine receptor ligands and ethanol in rats trained to discriminate pregnanolone.
    Vanover KE
    Pharmacol Biochem Behav; 2000 Nov; 67(3):483-7. PubMed ID: 11164076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lorazepam substitutes for the alcohol stimulus in social drinkers.
    Jackson A; Stephens DN; Duka T
    Psychopharmacology (Berl); 2003 Mar; 166(2):181-7. PubMed ID: 12529807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus properties of alprazolam.
    Gommans J; Hijzen TH; Maes RA; Olivier B
    Psychopharmacology (Berl); 2000 Feb; 148(2):146-52. PubMed ID: 10663429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug discrimination: stimulus control during repeated testing in extinction.
    Zarcone TJ; Ator NA
    J Exp Anal Behav; 2000 Nov; 74(3):283-94. PubMed ID: 11218226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.
    Kohut SJ; Ator NA
    Pharmacol Biochem Behav; 2008 Jul; 90(1):65-73. PubMed ID: 18395780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies.
    Rowlett JK; Woolverton WL
    Psychopharmacology (Berl); 1996 Nov; 128(1):1-16. PubMed ID: 8944400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased specificity of ethanol's discriminative stimulus effects in an ethanol-pentobarbital-water discrimination in rats.
    Bowen CA; Grant KA
    Drug Alcohol Depend; 1999 Jun; 55(1-2):13-24. PubMed ID: 10402145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
    de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
    J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
    Reynolds DS
    Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug discrimination analysis of partial agonists at the benzodiazepine site. I. Differential effects of U-78875 across training conditions in baboons and rats.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1434-46. PubMed ID: 10336537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discriminative stimulus effects of alprazolam and diazepam: generalization to benzodiazepines, antidepressants and buspirone.
    Wettstein JG; Gauthier B
    Behav Pharmacol; 1992 Jun; 3(3):229-237. PubMed ID: 11224120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral analysis of zopiclone on the basis of their discriminative stimulus properties in the rat.
    Yamamoto T; Kumasaka Y; Ueki S
    Jpn J Pharmacol; 1989 Nov; 51(3):337-45. PubMed ID: 2576082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some behavioral effects of chlorodesmethyldiazepam and lorazepam.
    Kostowski W; Płaźnik A; Puciłowski O; Trzaskowska E; Lipińska T
    Pol J Pharmacol Pharm; 1981; 33(6):597-602. PubMed ID: 6127668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.